Manufacturers hunting ways to cut their dependence on Chinese suppliers just got another option. Bengaluru-based Scimplify collected $25M in an all-equity strategic round that values the three-year-old company at $250M, TechCrunch reported.
Hitachi Ventures led the raise. Customers Henkel and Teknor Apex came in as new backers, while Accel India, Bertelsmann India Investments, Omnivore and 3one4 Capital followed on. The customer-investor overlap is unusual and signals that Scimplify’s buyers want a stake in the capacity they depend on.
The hard part of specialty chemicals has never been invention. It is scale. Turning promising chemistry into products a factory can actually order takes years of process development and facility qualification. Scimplify attacks that gap with Scinode, a proprietary platform that coordinates process design across its Bengaluru and Hyderabad research sites before handing production to partner plants.
Co-founder Sachin Santhosh says the compressed timeline is the pitch. Some orders now travel from customer requirements to delivered material in two months, against the 12 to 18 months the work typically consumes.
That speed is the whole thesis. Advanced computing has made materials discovery faster, but the industrial bottleneck sits downstream of the lab, in the unglamorous business of proving a process works at volume.
Scimplify’s bet is that whoever industrializes fastest wins customers who otherwise have few Western alternatives. The round gives it capital to expand that capacity at the moment supply-chain diversification has become a board-level priority.
